Showing 2,181 - 2,200 results of 4,761 for search '"Xiamen University"', query time: 0.14s Refine Results
  1. 2181
  2. 2182
  3. 2183
  4. 2184
  5. 2185
  6. 2186
  7. 2187
  8. 2188
  9. 2189
  10. 2190
  11. 2191
  12. 2192
  13. 2193
  14. 2194
  15. 2195
  16. 2196

    Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma by Lian CL, Zhou R, Zhou Y, Zhou P, Wu SG

    Published 2023-02-01
    “…Chen-Lu Lian,1– 3,* Rui Zhou,2,* Yuan Zhou,2,* Ping Zhou,2 San-Gang Wu1,2 1The School of Clinical Medicine, Fujian Medical University, Fuzhou, People’s Republic of China; 2Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People’s Republic of China; 3Department of Radiation Oncology, Fudan University Shanghai Cancer Center (Xiamen Branch), Xiamen, People’s Republic of China*These authors contributed equally to this workCorrespondence: San-Gang Wu, Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361003, People’s Republic of China, Email unowu12345@hotmail.comPurpose: To compare the short-term treatment response and survival of the three induction chemotherapy (IC) regimens, including gemcitabine and cisplatin (GP), docetaxel and cisplatin (TP), and docetaxel, cisplatin, and fluoropyrimidines (TPF) in locally advanced nasopharyngeal carcinoma (LANPC).Methods: We included stage III–IVA NPC patients who received ≥ 3 cycles of IC in this study. …”
    Get full text
    Article
  17. 2197
  18. 2198
  19. 2199
  20. 2200